Evidence map›Paper›PMID 14980308›Full record

ArticleJournal of the Society for Gynecologic Investigation2004

High glucose levels down-regulate glucose transporter expression that correlates with increased oxidative stress in placental trophoblast cells in vitro.

Hui Li, Yang Gu, Yanping Zhang, Michael J Lucas, Yuping Wang

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Journal of the Society for Gynecologic Investigation, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02694263 (A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02694263 phase4completedstarted 2016, after this paper: background citation

A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan: Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen: The 'Can Do Ramadan' Study

Ran2016Enrolled25Registered outcomes32Posted comparisons0ConditionsDiabetes Mellitus, Type 2ArmsCanagliflozin, Gliclazide, Glimepiride, Pioglitazone, Repaglinide
Open the trial in the graph
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Role of Placental Glucose Transporters in Determining Fetal Growth.Reproductive sciences (Thousand Oaks, Calif.) · 2022
    Review
  4. Article
  5. Human placental glucose transport in fetoplacental growth and metabolism.Biochimica et biophysica acta. Molecular basis of disease · 2020
    Review
  6. Article
  7. Single Nucleotide Polymorphisms inAnimals : an open access journal from MDPI · 2019
    Article
  8. Article
  9. Oxidative Stress in Preeclampsia and Placental Diseases.International journal of molecular sciences · 2018
    Review
  10. Mammary alveolar cell asAsian-Australasian journal of animal sciences · 2017
    Article
  11. SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.Nature reviews. Endocrinology · 2012 · on this map
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hui LiDepartment of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA.
Yang Gu
Yanping Zhang
Michael J Lucas
Yuping Wang
Louisiana State University Health Sciences Center Shreveport · US

Funding

ENDOTHELIAL BARRIER FUNCTION IN PREECLAMPSIAR01HL065997 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI WANG, YUPING · 2001 to 2010
$1.8M
PLACENTAL FUNCTION IN PREECLAMPSIAR01HD036822 · NICHD · LOUISIANA STATE UNIV HSC SHREVEPORT · PI WANG, YUPING · 1999 to 2009
$1.3M
NHLBI NIH HHS HL 65997NICHD NIH HHS HD36822
6 · The paper itself

Abstract

objectiveTo study glucose transporter expression and oxidative stress in placental trophoblasts under hyperglycemic conditions in vitro.

methodsTrophoblasts were isolated from term normal human placentas and incubated with Dulbecco's modified eagle medium containing 1000, 2500, and 4500 mg/L glucose for 3 days. At the end of incubation, culture medium was collected. Trophoblast RNA was extracted and mRNA expression of glucose transporters was determined by RNase protection assay. Messenger RNA expression for copper-zinc-superoxide dismutase (CuZn-SOD) was determined by real-time polymerase chain reaction. Lipid peroxide production was determined by measuring malondialdehyde concentration in the culture supernatant. Protein expression of sodium-glucose transporter 2 (SGLT-2) was determined by Western blot analysis.

resultsMessenger RNA expression for glucose transporter 1 (GLUT1) and SGLT-2 were reduced in trophoblast cells incubated with 4500 mg/L glucose compared with those incubated with 1000 and 2000 mg/L glucose. mRNA expression of CuZn-SOD was also decreased in trophoblasts incubated with 4500 mg/L glucose. Malondialdehyde production was significantly increased by trophoblasts incubated with 4500 mg/L glucose compared with those by trophoblasts incubated with 1000 and 2000 mg/L glucose (4.69 +/- 0.60 versus 2.10 +/- 0.29 and 2.89 +/- 0.47 nmol/mg protein; P < .01, respectively).

conclusionsDown-regulation of gene expression of glucose transporters correlates with increased lipid peroxide production and decreased superoxide dismutase expression in placental trophoblasts cultured under hyperglycemic conditions.

Indexed as

Cells, CulturedFemaleGene Expression RegulationGlucoseGlucose Transporter Type 1HumansMalondialdehydeMonosaccharide Transport ProteinsOxidative StressPregnancyReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSuperoxide DismutaseTrophoblastsGlucoseGlucose Transporter Type 1MalondialdehydeMonosaccharide Transport ProteinsRNA, MessengerSLC2A1 protein, humanSuperoxide Dismutase

Identifiers

PMID14980308
OpenAlexW2037187855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.